Atai Life Sciences N.V. (ATAI)

NASDAQ: ATAI · IEX Real-Time Price · USD

2.050

+0.070 (3.54%)

At close: May 1, 2024, 4:00 PM

2.010

-0.040 (-1.95%)

After-hours: May 1, 2024, 7:54 PM EDT

Atai Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	343	234	441	1,223	-	-
Market Cap Growth	-	-46.95%	-63.92%	-	-	-
Enterprise Value	183	73	183	861	-95	-38
PE Ratio	-5.82	-5.82	-2.89	-7.29	-	-
PS Ratio	1092.98	745.46	1893.68	60.03	-	-
PB Ratio	1.41	0.96	1.69	3.25	-	-
P/FCF Ratio	-2.76	-2.76	-4.18	-19.00	-	-
P/OCF Ratio	-2.78	-2.78	-4.22	-19.34	-	-
EV/Sales Ratio	581.45	233.93	787.38	42.24	-	-
EV/EBITDA Ratio	-2.05	-2.05	-1.26	-5.01	0.56	2.70
EV/EBIT Ratio	-2.01	-2.01	-1.26	-5.01	0.56	2.70
EV/FCF Ratio	-0.87	-0.87	-1.74	-13.37	4.58	4.85
Debt / Equity Ratio	0.08	0.08	0.06	0.00	0.02	0.00
Debt / EBITDA Ratio	-0.53	-0.53	-0.11	0.00	-0.01	-0.01
Debt / FCF Ratio	-0.23	-0.23	-0.15	-0.01	-0.10	-0.02
Quick Ratio	8.93	8.93	13.73	17.35	7.93	23.84
Current Ratio	9.22	9.22	14.43	17.92	8.10	24.36
Asset Turnover	0.00	0.00	0.00	0.05	0	-
Interest Coverage	-13.76	-13.76	-157.35	-	-	-
Return on Equity (ROE)	-16.80%	-16.80%	-50.50%	-47.40%	-227.10%	-
Return on Assets (ROA)	-14.20%	-14.20%	-44.10%	-43.30%	-195.60%	-
Return on Capital (ROIC)	-47.87%	-47.87%	-52.44%	-35.96%	-112.00%	-30.30%
Earnings Yield	-11.72%	-17.18%	-34.54%	-13.72%	-	-
FCF Yield	-24.68%	-36.19%	-23.91%	-5.26%	-	-
Buyback Yield / Dilution	-2.00%	-2.00%	-12.62%	-48.64%	-7.34%	-
Total Shareholder Return	-2.00%	-2.00%	-12.62%	-48.64%	-7.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).